Glenn Greenberg recent buys & sells (2014 Q3)
Brave Warrior Advisors
Brave Warrior Advisors Portfolio Changes
Purchase & sale details
- Portfolio value:
- $2.70B (+$219M)
- Previous value:
- $2.48B
- # of changes:
- 11
- New positions:
- 1
- Reported for:
- 30 Sep 2014 (Q3)
- Latest filing date:
- 14 Nov 2014
Brave Warrior Advisors has disclosed a total of 11 changes to the portfolio in the (2014 Q3) SEC report(s): increased the number of shares of 4, bought 1 totally new, decreased the number of shares of 4 and completely sold out 2 position(s).
What stocks did Glenn Greenberg buy in 2014 Q3?
During 2014 Q3 Glenn Greenberg has purchased 5 securities: (VRX) Valeant Pharmaceuticals International Inc (added shares +8.86%), (ESRX) Express Scripts Holding Co (added shares +6.50%), (VPRT) VISTAPRINT NV ORD SHS (NL) (added shares +26.15%), (JPM) JPMorgan Chase & Co (new buy) and (EQIX) Equinix Inc (added shares +42.72%).
What did Glenn Greenberg invest in during 2014 Q3?
In the 2014 Q3 report(s) the following changes have been made to the top investments: (VRX) Valeant Pharmaceuticals International Inc (added shares +8.86%), (ESRX) Express Scripts Holding Co (added shares +6.50%), (VPRT) VISTAPRINT NV ORD SHS (NL) (added shares +26.15%), (SCHW) Charles Schwab Corp (reduced shares -0.04%) and (KMR) KINDER MORGAN MANAGEMENT LLC (reduced shares -15.45%).
11 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
JPMorgan Chase & Co
|
new
|
$60.24
|
+457.80%($336.02)
|
8.13%
|
2014 Q3
|
~0.25 years
|
||||
|
|
Equinix Inc
|
+42.72%
|
$206.09
|
+372.25%($973.27)
|
5.72%
|
2014 Q2
|
~0.50 years
|
||||
|
|
VISTAPRINT NV ORD SHS (NL)
|
+26.15%
|
$54.79
|
|
9.30%
|
2013 Q2*
|
> 1 years
|
||||
|
|
Valeant Pharmaceuticals International Inc
|
+8.86%
|
$131.20
|
|
32.02%
|
2013 Q2*
|
> 1 years
|
||||
|
|
Express Scripts Holding Co
|
+6.50%
|
$70.63
|
|
13.04%
|
2013 Q2*
|
> 1 years
|
||||
|
|
Charles Schwab Corp
|
-0.04%
|
$29.39
|
+206.45%($90.06)
|
9.09%
|
2013 Q2*
|
> 1 years
|
||||
|
|
Microsoft Corp
|
-0.10%
|
$46.36
|
+1,051.63%($533.90)
|
8.30%
|
2013 Q3
|
~1.25 years
|
||||
|
|
Primerica Inc
|
-0.79%
|
$48.22
|
+482.57%($280.92)
|
5.95%
|
2013 Q2*
|
> 1 years
|
||||
|
|
KINDER MORGAN MANAGEMENT LLC
|
-15.45%
|
$94.15
|
|
8.37%
|
2013 Q4
|
~1.00 year
|
||||
|
|
Halliburton Company
|
-100%
|
$71.01
|
-54.06%($32.62)
|
0.00%
|
2013 Q2*
|
> 1 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".